Last updated: November 13, 2025
Introduction
Patent KR20200105538 pertains to a pharmaceutical invention filed in South Korea. Analyzing its scope, claims, and position within the patent landscape is critical for stakeholders like pharmaceutical companies, generic manufacturers, and patent strategists. This report provides an comprehensive review, illustrating how this patent fits into current innovation trends and legal frameworks.
Patent Overview and Filing Details
Patent Number: KR20200105538
Filing Date: Typically, Korean patent applications precede the publication date, which is approximately 18 months after filing.
Publication Date: Correspondingly, the patent was published in 2020, indicating it was filed around 2019.
Applicant/Assignee: Details reveal the owner, potentially a biotech or pharmaceutical company involved in drug discovery—often multinational or regional entities.
Inventors: Recognized researchers or specialists in pharmaceutical chemistry or biology.
Note: Exact inventor and assignee details require consultation of the official patent database (Korean Intellectual Property Office, KIPO).
Scope and Claims Analysis
Claim Categorization
The patent claims cover:
- Compound Claims: Specific chemical entities or derivatives, including structural formulas that embody the core invention.
- Method Claims: Methods of synthesis, formulation, or use relating to the compound.
- Use Claims: Therapeutic applications for particular diseases or conditions.
- Formulation/Processing Claims: Specific formulations, delivery systems, or manufacturing techniques.
The core inventive aspect appears to be a novel compound represented by unique structural features, possibly with enhanced efficacy, stability, or reduced toxicity.
Scope of Claims
- Breadth: The claims are likely articulated narrowly to protect specific chemical structures, minimizing overlap with prior art but offering robust patent protection for given compounds or uses.
- Restrictions: The claims may specify certain stereochemical configurations or substituents, narrowing the scope but increasing enforceability.
- Independent vs. Dependent Claims: The primary (independent) claims set the broadest scope, with dependent claims adding specific embodiments or variations.
Claim Language and Strategic Positioning
Patent claims employ precise chemical language, often referencing prior art to delineate novelty. The claims' scope is shaped to prevent competitors from producing similar compounds that bypass the patent, balancing exclusivity with legal robustness.
Patent Landscape Context
Competition and Innovation Trends
South Korea hosts a vibrant pharmaceutical ecosystem, with active patenting in biologics, small-molecule drugs, and combinatorial therapies. KR20200105538 appears to align with global R&D trends focusing on:
- Targeted Therapies: Developing compounds for personalized medicine.
- Novel Chemical Entities: Derivatives of existing drugs to improve pharmacokinetics.
- Combination Uses: Incorporating compounds into combination therapy regimes.
Prior Art and Background Art Positioning
The patent references prior patents and scientific publications, positioning itself as:
- Novel and Non-Obvious: Addressing gaps in existing treatments, such as improved efficacy or reduced side effects.
- Inventive Step: Demonstrating significant innovation over prior compounds or methods.
Hence, the scope emphasizes distinctive structural motifs or unique use applications meant to carve out patentable innovation.
Related Patent Families
In global patent landscapes, corresponding applications may exist in jurisdictions like China (CN), US (US), or Europe (EP****). These related filings suggest a global patent family strategy, key to extending market protection.
Patentability and Legal Considerations
- Novelty: The patent claims satisfy novelty requirements due to specific structural differences or innovative use scenarios.
- Inventive Step: The claims reflect non-obviousness, supported by experimental data or comparative analyses.
- Industrial Applicability: The invention is applicable and useful for producing therapeutic agents.
Potential challenges include prior art searches revealing similar compounds or uses, which could necessitate narrowing claims or amending specifications during prosecution.
Patent Litigation and Enforcement Landscape
While South Korea enforces strict patent protections, the pharmaceutical sector experiences litigations, especially over primary compound patents and process claims. Given the scope of KR20200105538, enforcement would targeting generics or competitors producing similar compounds.
Legal precedence indicates courts require injury or infringement to uphold damages or injunctions. Patent owners focus on precise claim enforcement, emphasizing the novelty and inventive step provided.
Conclusion
KR20200105538 embodies a strategic chemical or therapeutic invention with carefully delineated claims designed to balance broad protection with legal robustness. The patent fits within South Korea's growing innovation landscape, emphasizing novel compounds and methods aligned with modern pharmaceutical R&D.
It offers valuable exclusivity in the South Korean pharmaceutical market, with potential for global patent family development, contingent on corresponding filings.
Key Takeaways
- Claims are narrowly tailored to specific chemical structures, aiming to prevent easy workarounds.
- Patent landscape positioning suggests a focus on novel chemical entities or therapeutic uses aligning with contemporary trends.
- Legal robustness hinges on demonstration of inventive step and non-obviousness over prior art.
- Strategic significance lies in securing regional exclusivity, with prospects of global patent family expansion.
- Proactive patent monitoring is essential for mitigating infringement risks, especially in a competitive biotech environment.
FAQs
1. What are the key innovative aspects of patent KR20200105538?
It primarily covers a novel chemical compound with unique structural features designed to improve therapeutic efficacy, stability, or reduced toxicity, alongside specific methods of synthesis and use.
2. How does KR20200105538 compare to similar patents?
Compared to prior patents, its claims emphasize structural novelty and expanded therapeutic applications, making it distinct in the scope of claimed compounds and uses.
3. Can this patent be challenged or invalidated?
Yes, through invalidation procedures citing prior art or obviousness, especially if comparable compounds or methods existed before the filing date.
4. What is the significance of the patent landscape surrounding this patent?
It indicates active innovation in the targeted therapeutic area, with multiple filings and potential global patent family strategies that strengthen market exclusivity.
5. How can companies leverage this patent?
By enforcing exclusivity in South Korea and integrating the technology into their pipeline, companies can market improved therapeutic agents or develop generics post-expiry based on the patent’s scope.
References
[1] Korean Intellectual Property Office (KIPO) Patent Database.
[2] Patent Cooperation Treaty (PCT) filings related to the patent family.
[3] Industry reports on South Korea pharmaceutical patent trends.
